Lv5
1170 积分 2024-01-30 加入
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy
1个月前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
1个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
1个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
1个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
1个月前
已完结
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial
2个月前
已完结
Targeted protein degradation: from mechanisms to clinic
2个月前
已完结
Molecular glue degraders: exciting opportunities for novel drug discovery
2个月前
已完结
Amylin: Pharmacology, Physiology, and Clinical Potential
2个月前
已完结
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616
2个月前
已完结
皖公网安备34019202002308
